6 results
Responsible body
CHMP Remove CHMP filter
-
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,17-19 March 2008
CHMP, Last updated: 20/03/200818 years of age. Zevalin (ibritumomab tiuxetan), from Schering AG, to extend … -
List item
Committee for Medicinal Products for Human Use (CHMP): 9-12 October 2017
European Medicines Agency, London, UK, from 09/10/2017 to 12/10/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 January 2017
European Medicines Agency, London, UK, from 23/01/2017 to 26/01/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 15-18 May 2017
European Medicines Agency, London, UK, from 15/05/2017 to 18/05/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 18-21 April 2017
European Medicines Agency, London, UK, from 18/04/2017 to 21/04/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 7-10 November 2016
European Medicines Agency, London, UK, from 07/11/2016 to 10/11/2016, Last updated: 06/01/2014